News and Events
Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.
Featured News Item
5 years in, RECOVER continues to advance its patient-centered mission
RECOVER marks 5 years of Long COVID research, with NIH leaders, scientists, and clinicians continuing to guide and advance the initiative’s mission. In 2026, RECOVER will expand clinical trials to find answers for the Long COVID community.
News Release
151 Results
151 Results
RECOVER-ENERGIZE clinical trials achieve early enrollment: How collaboration and communication drove success
A network of 42 RECOVER sites across the US worked to reach out to potential study participants, communicate with the trial team, and reach the trials’ enrollment goal 2 months ahead of schedule.
Feature
Over 1.4 million biosamples available in RECOVER’s biorepository to support Long COVID research
Biostatisticians and clinicians work together to help funded study teams access resources stored in RECOVER’s biorepository, a unique collection of biosamples from almost 30,000 adults and children.
Feature
RECOVER-TLC invites public comments on upcoming clinical trials
Feedback from patients, caregivers, and others will help shape studies testing the safety and effectiveness of potential Long COVID treatments.
Announcement
Study reveals insights into Long COVID trajectories in adults
A study from Mass General Brigham followed 3,659 adults to identify eight different paths that Long COVID can take, based on symptoms and length of illness. The results will inform future studies and possible treatments for Long COVID.
News Release
R3 Seminar Recap: Long COVID in older adults: Insights from the RECOVER adult observational cohort
During the October 28 RECOVER Research Review (R3) seminar, RECOVER researchers Samantha Russell, MD, and Janko Nikolich, MD, PhD, MSc, presented their published papers on Long COVID in older adults. Dr. Russell discussed a review article on Long COVID in older adults, which was published in 2024. Dr. Nikolich shared findings from the RECOVER observational study that compared Long COVID symptoms across different age groups. Quinn Barnette, MPH, facilitated the discussion.
R3 Seminar Recap
RECOVER-NEURO clinical trial shares results of three non-drug treatments for cognitive symptoms of Long COVID
Results from the RECOVER-NEURO clinical trial were published in the journal JAMA Neurology. The trial focused on symptoms of cognitive dysfunction associated with Long COVID, including brain fog, trouble focusing, and thinking clearly.
News Release
RECOVER biosamples and data advance understanding of what may cause Long COVID
RECOVER pathobiologists have designed a large, collaborative, and innovative study that can help to develop diagnostics for specific types of Long COVID.
Feature
Mother and daughter RECOVER Representatives share their journey of recovery, caregiving, and advocacy
A mother living with Long COVID and her daughter, who supports her as a caregiver, share their motivations to join the RECOVER Initiative as Representatives.
Feature